Publicacións en colaboración con investigadores/as de Medical University of Vienna (2)

2020

  1. CRISPR/Cas9-generated models uncover therapeutic vulnerabilities of del(11q) CLL cells to dual BCR and PARP inhibition

    Leukemia, Vol. 34, Núm. 6, pp. 1599-1612

2016

  1. Do we need new high-risk criteria for surgically treated renal cancer patients to improve the outcome of future clinical trials in the adjuvant setting? Results of a comprehensive analysis based on the multicenter CORONA database

    European Journal of Surgical Oncology, Vol. 42, Núm. 5, pp. 744-750